Naphthoquinone	B:C0027388
glycosides	B:C0017977
for	O
bioelectroanalytical	O
enumeration	O
of	O
the	O
faecal	B:C0015733
indicator	B:C0021212
Escherichia	B:C0014834
coli	I:C0014834
.	O

Microbial	O
water	O
quality	O
monitoring	B:C1283169
for	O
the	O
presence	O
of	O
faecal	B:C0004611
indicator	I:C0004611
bacteria	I:C0004611
(	O
faecal	B:C0004611
indicator	I:C0004611
bacteria	I:C0004611
)	O
is	O
a	O
mandatory	O
activity	O
in	O
many	O
countries	B:C0454664
and	O
is	O
key	O
in	O
public	B:C0034020
health	I:C0034020
protection	I:C0034020
.	O

Despite	O
technological	O
advances	O
and	O
a	O
need	O
for	O
methodological	O
improvements	O
,	O
chromogenic	B:C3872799
and	O
fluorogenic	O
enzymatic	O
techniques	O
remain	O
the	O
mainstays	O
of	O
water	O
quality	O
monitoring	B:C1283169
for	O
both	O
public	B:C1551248
health	I:C1551248
agencies	I:C1551248
and	I:C1551248
regulated	I:C1551248
utilities	I:C1551248
.	O

We	O
demonstrated	O
that	O
bioelectroanalytical	B:C0936012
approaches	I:C0936012
to	O
faecal	B:C0004611
indicator	I:C0004611
bacteria	I:C0004611
enumeration	O
are	O
possible	O
and	O
can	O
be	O
achieved	O
using	O
commercially	O
available	O
enzyme	B:C0014442
-	O
specific	O
resorufin	B:C0073089
glycosides	B:C0017977
,	O
although	O
these	O
are	O
expensive	O
,	O
not	O
widely	O
available	O
or	O
designed	O
for	O
purpose	O
.	O

Following	O
this	O
,	O
we	O
designed	O
two	O
naphthoquinone	B:C0027388
glycosides	B:C0017977
which	O
performed	O
better	O
,	O
achieving	O
Escherichia	B:C1294359
coli	I:C1294359
detection	I:C1294359
in	O
the	O
range	O
5.0	O
×	O
10	O
(	O
2	O
)	O
to	O
5.0	O
×	O
10	O
(	O
5	O
)	O
CFU	O
ml(	O
-	O
1	O
)	O
22	O
-	O
54	O
%	O
quicker	O
than	O
commercially	O
available	O
resorufin	B:C0073089
glycosides	B:C0017977
.	O

The	O
molecular	O
design	O
of	O
the	O
naphthoquinone	B:C0027388
glycosides	B:C0017977
requires	O
fewer	O
synthetic	O
steps	O
allowing	O
them	O
to	O
be	O
produced	O
for	O
as	O
little	O
as	O
US	O
$	O
50	O
per	O
kg	O
.	O

Tests	O
with	O
environmental	B:C0014406
samples	O
demonstrated	O
the	O
low	O
tendency	O
for	O
abiotic	O
interference	O
and	O
that	O
,	O
despite	O
specificity	O
being	O
maintained	O
between	O
β-	B:C0017776
glucuronidase	I:C0017776
and	O
β-	B:C0005220
galactosidase	I:C0005220
,	O
accurate	O
enumeration	O
of	O
E.	B:C0014834
coli	I:C0014834
in	O
environmental	B:C0014406
samples	O
necessitates	O
development	O
of	O
a	O
selective	O
medium	O
.	O

In	O
comparison	O
to	O
a	O
commercially	O
available	O
detection	B:C0442726
method	O
,	O
which	O
has	O
U.S.	B:C0041712
Environmental	I:C0041712
Protection	I:C0041712
Agency	I:C0041712
(	O
Environmental	B:C0041712
Protection	I:C0041712
Agency	I:C0041712
)	O
approval	B:C2346845
,	O
our	O
approach	O
performed	O
better	O
at	O
high	O
organism	O
concentrations	O
,	O
detecting	O
500	O
organisms	O
in	O
9	O
h	O
compared	O
with	O
13.5	O
h	O
for	O
the	O
commercial	B:C0871511
method	I:C0871511
.	O

Bioelectroanalytical	B:C0936012
detection	I:C0936012
is	O
comparable	O
to	O
current	B:C0871511
approved	I:C0871511
methods	I:C0871511
and	O
with	O
further	B:C0243107
development	I:C0243107
could	O
result	O
in	O
improved	O
detection	B:C0442726
times	O
.	O

A	O
recent	O
trend	O
for	O
low	O
-	O
cost	O
open	O
-	O
source	O
hardware	O
means	O
that	O
automated	O
,	O
potentiostatically	O
controlled	O
E.	B:C1294359
coli	I:C1294359
detection	I:C1294359
systems	O
could	O
be	O
constructed	O
for	O
less	O
than	O
US	O
$	O
100	O
per	O
channel	O
.	O

